Waterfront Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Hold
2,041
0.05% 251
2026
Q1
$261K Hold
2,041
0.05% 251
2025
Q4
$261K Buy
2,041
+1
+0% +$115 0.05% 246
2025
Q3
$219K Buy
+2,040
New +$184K 0.04% 250
2025
Q2
Sell
-2,654
Closed -$215K 271
2025
Q1
$215K Hold
2,654
0.05% 246
2024
Q4
$239K Buy
2,654
+100
+4% +$9.69K 0.06% 236
2024
Q3
$252K Hold
2,554
0.06% 231
2024
Q2
$237K Sell
2,554
-750
-23% -$67.2K 0.06% 225
2024
Q1
$271K Buy
3,304
+300
+10% +$27.8K 0.08% 214
2023
Q4
$268K Buy
+3,004
New +$223K 0.08% 214
2023
Q3
Sell
-3,504
Closed -$292K 256
2023
Q2
$292K Sell
3,504
-100
-3% -$8.36K 0.09% 203
2023
Q1
$275K Hold
3,604
0.09% 209
2022
Q4
$322K Sell
3,604
-1,250
-26% -$101K 0.11% 196
2022
Q3
$397K Sell
4,854
-803
-14% -$67.7K 0.15% 168
2022
Q2
$420K Buy
5,657
+1,195
+27% +$89.7K 0.17% 159
2022
Q1
$408K Buy
4,462
+1,983
+80% +$183K 0.14% 155
2021
Q4
$278K Buy
+2,479
New +$299K 0.11% 180

Other funds holding XBI

Waterfront Wealth's XBI Position: Q2 2026 in Review

Waterfront Wealth held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,041 shares worth $325K. The position accounts for 0.05% of the portfolio, ranked #251.

Waterfront Wealth first reported a position in XBI in Q4 2021 and has held it in 17 quarters since. The position peaked at $420K in Q2 2022. 368 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Waterfront Wealth held 2,041 shares of State Street SPDR S&P Biotech ETF worth $325K as of Q2 2026.
  • Waterfront Wealth left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Waterfront Wealth's portfolio in Q2 2026, its #251 holding.
  • Waterfront Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 17 quarters since.
  • Waterfront Wealth's State Street SPDR S&P Biotech ETF position peaked at $420K in Q2 2022.
  • 368 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.